Related Parties (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Feb. 18, 2022	May 07, 2021
Offsetting Assets [Line Items]
Research and development expenses	$ 1,048,457	$ 1,456,119
Accrued consulting fees	238,000	$ 137,500
16 Accredited Investors and 5 Board Members [Member]
Offsetting Assets [Line Items]
Convertible Notes Payable			$ 341,632
5 Accredited Investors and 3 Board Members [Member] | Convertible Notes Payable [Member]
Offsetting Assets [Line Items]
Convertible Notes Payable				$ 575,000
5 Accredited Investors and 3 Board Members [Member] | Convertible Notes Payable [Member] | 3 Board Members [Member]
Offsetting Assets [Line Items]
Convertible Notes Payable				$ 225,000
5 Board Members [Member] | 16 Accredited Investors and 5 Board Members [Member]
Offsetting Assets [Line Items]
Convertible Notes Payable			$ 155,000
Consulting Agreements [Member] | Dr Steinmetz [Member]
Offsetting Assets [Line Items]
Research and development expenses	60,000
Consulting Agreements [Member] | Dr Pokorski [Member]
Offsetting Assets [Line Items]
Research and development expenses	30,000
Consulting Agreements [Member] | Dr Fiering [Member]
Offsetting Assets [Line Items]
Research and development expenses	$ 30,000